Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed BackBenzinga • 12/15/21
GlaxoSmithKline/Sanofi Covid-19 vaccine effective as booster shot, trial showsProactive Investors • 12/15/21
Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendationGlobeNewsWire • 12/15/21
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed PatientsBenzinga • 12/13/21
Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline of innovative vaccine candidatesGlobeNewsWire • 12/01/21
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapyGlobeNewsWire • 12/01/21
Sanofi offers all employees worldwide 14 weeks paid parental leave to ensure workplace equalityPRNewsWire • 11/30/21
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy developmentReuters • 11/22/21
Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipelineGlobeNewsWire • 11/18/21